These cytokines represent complementary aspects of the tumor microenvironment: pro-inflammatory and tumor-promoting signaling (IL-6, IL-1β, TNF-α), anti-inflammatory modulation (IL-10), and Th17-driven immune activity (IL-17). This evidence concerns the gene IL17A and neoplasm.